| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
phenotype | 0.400 | None | 0.982 | 162 | 2 | 1994 | 2020 | ||||||||
|
S100 calcium binding protein A4 | 0.448 | 0.769 | 6.2E-03 |
|
phenotype | 0.400 | None | 0.962 | 158 | 0 | 1992 | 2020 | ||||||||
|
CEA cell adhesion molecule 5 | 0.420 | 0.846 | 4.2E-10 |
|
phenotype | 0.100 | None | 0.939 | 148 | 0 | 1989 | 2020 | ||||||||
|
twist family bHLH transcription factor 1 | 0.397 | 0.846 | 0.34 |
|
phenotype | 0.400 | None | 0.980 | 147 | 0 | 2004 | 2019 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
phenotype | 0.100 | None | 0.986 | 145 | 5 | 1997 | 2020 | ||||||||
|
CD82 molecule | 0.507 | 0.731 | 1.3E-08 |
|
phenotype | 0.600 | None | 0.973 | 144 | 0 | 1995 | 2019 | ||||||||
|
metastasis associated lung adenocarcinoma transcript 1 | 0.435 | 0.846 |
|
phenotype | 0.400 | None | 0.993 | 142 | 1 | 2003 | 2020 | |||||||||
|
vimentin | 0.372 | 0.846 | 0.71 |
|
phenotype | 0.400 | None | 0.986 | 140 | 0 | 1997 | 2020 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
phenotype | 0.400 | None | 0.972 | 139 | 3 | 1995 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.600 | None | 0.968 | 139 | 0 | 1998 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
phenotype | 0.100 | None | 0.986 | 138 | 0 | 1994 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
phenotype | 0.100 | None | 0.942 | 137 | 2 | 1992 | 2020 | ||||||||
|
heparanase | 0.425 | 0.808 | 2.3E-14 |
|
phenotype | 0.400 | None | 0.972 | 136 | 0 | 1999 | 2020 | ||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
phenotype | 0.400 | None | 0.986 | 135 | 0 | 1993 | 2019 | ||||||||
|
zinc finger E-box binding homeobox 1 | 0.442 | 0.808 | 0.97 |
|
phenotype | 0.100 | None | 0.978 | 135 | 2 | 2006 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
phenotype | 0.400 | None | 0.978 | 132 | 1 | 1992 | 2020 | ||||||||
|
single-strand-selective monofunctional uracil-DNA glycosylase 1 | 0.322 | 0.923 | 4.5E-04 |
|
phenotype | 0.100 | None | 0.984 | 125 | 0 | 2017 | 2020 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
phenotype | 0.100 | None | 0.976 | 125 | 0 | 2007 | 2019 | |||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 125 | 0 | 1996 | 2019 | ||||||||
|
folate hydrolase 1 | 0.453 | 0.885 | 6.2E-09 |
|
phenotype | 0.100 | None | 0.983 | 115 | 0 | 1997 | 2020 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
phenotype | 0.400 | None | 0.991 | 111 | 0 | 2003 | 2020 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.982 | 109 | 1 | 2005 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.100 | None | 0.925 | 105 | 0 | 1995 | 2020 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
phenotype | 0.400 | None | 0.990 | 102 | 0 | 1989 | 2019 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
phenotype | 0.400 | None | 0.981 | 100 | 0 | 1990 | 2019 |